top of page
  • Bravado Team

A White Paper, from Brian McMillan

The Journey of Bravado Pharmaceutcals and the Development of CoVer Nasal Antibody Drops

Bravado invites you to read a white paper recently written by our founder, Brian McMillan, for Pharmaceutical Technology regarding development of "Cover Nasal Antibody Drops" during the CV-19 pandemic.

Bravado Pharmaceuticals developed this product in conjunction with Stanford University and SPARKGLOBAL.

The program was led by Professor Daria Mochly Rosen of Stanford and SPARKGLOBAL.

See our White Paper HERE

55 views0 comments
bottom of page